Back to CIBC Private Wealth Group LLC CIBC Private Wealth Group LLC

AZNAZN
Showing 6 of 29 quarters

Position history for CIBC Private Wealth Group LLCCIBC Private Wealth Group LLC's holdings in ASTRAZENECA PLC

As of its last 13F, for Q4 2025, CIBC Private Wealth Group held 8,081,817 shares of AZN (AstraZeneca), worth $743M. It reduced the position by 72,331 shares (-0.9%) from Q3 2025. CIBC Private Wealth Group held AZN from Q4 2018 to Q4 2025, across 29 quarterly 13F filings. AZN was 1.3% of CIBC Private Wealth Group's reported 13F portfolio.

Current Value

$743M

Current Shares

8.1M

Total Value Change

+$34.7M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
8.1M
-0.9%
$743M1.3%$181.96
0
2025-Q3
Decreased
8.2M
-0.9%
$625.6M1.1%$151.86
0
2025-Q2
Increased
8.2M
+0.2%
$575.3M1.0%$137.36
49
2025-Q1
Increased
8.2M
+1.4%
$533.4M1.1%$144.48
50
2024-Q4
Decreased
8.1M
-10.8%
$539.7M1.0%$126.98
0
2024-Q3
Decreased
9.1M
-1.3%
$708.2M1.3%$150.99
0

Other major holders of AZN: PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used